Let Doctors Provide Reproductive Health Care Act

Right to Contraception Act (S. 422/H.R. 999) A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (S.J. Res. 732) Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (H.J. Res. 1285) EACH Act (S. 2377/H.R. 4611) Right to IVF Act (not yet introduced) FACE Act Repeal Act (H.R. 589) Reproductive Health Care Accessibility Act (H.R. 8829/S. 4540) To express the Sense of Congress with respect to safety of medication abortion and Federal preemption of State restrictions on dispensing medication abortion, and for other purposes. (H.R. 8734) Freedom to Travel for Health Care Act of 2026 (S. 4701) SAFE Training for OBGYNs Act (H.R. 9441) Let Doctors Provide Reproductive Health Care Act (S. 4879/H.R. 9445) Reproductive Health Travel Fund Act of 2026 (S. 4922) Reproductive Health Care Training Act (S. 4878) Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. (H.Res.1389) SAFER Health Act of 2026 (S. 4920/H.R. 9470)

Client expense: $652,972 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Right to Contraception Act (S. 422/H.R. 999) A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (S.J. Res. 732) Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (H.J. Res. 1285) SAFE Training for OBGYNs Act (H.R. 9441) Let Doctors Provide Reproductive Health Care Act (S. 4879/H.R. 9445) Reproductive Health Travel Fund Act of 2026 (S. 4922)

Client expense: $79,708 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The connection between reproductive freedom and the economy; Reproductive healthcare in FY26 and FY27 federal spending bills; A federal right to abortion; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions that restrict abortion access; H.R.4611 and S.2377, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act of 2025, regarding access to affordable health insurance plans that cover abortion; Abortion-coverage restrictions; S.4701, the Freedom to Travel for Health Care Act of 2026; S.4922, the Reproductive Health Travel Fund Act; H.R.9445 and S.4879, the Let Doctors Provide Reproductive Health Care Act; H.R.9441, the SAFE Training for OB-GYNs Act; Defunding Planned Parenthood, including amendment #4794 to the budget resolution S.Con.Res. 33; Issues related to violence and intimidation directed at reproductive-healthcare providers, including Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction, and property damage intended to interfere with reproductive health care services; Access to evidence-based medication abortion care; H.Res.1285 and S.Res.732 expressing the sense of Congress that mifepristone is safe and effective and law and policy governing access to medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science; H.R.8829 and S.4540, the Reproductive Health Care Accessibility Act; Veterans and their dependents access to reproductive health care; Access to reproductive health services for servicemembers and their dependents, including S.4574, the MARCH for Military Servicemembers Act; Anti-abortion centers/crisis pregnancy centers; H.R.999, the Right to Contraception Act; Access to treatments for infertility, including IVF; H.Res.1147, a Resolution to recognize the history of ignored pain and absence of autonomy in womens healthcare; Healthy pregnancy and post-partum period; H.Res.1268, recognizing the week of May 3, 2026, through May 9, 2026, as National Postpartum Awareness Week for Communities of Color; H.R.9470, the SAFER Health Act of 2026, to ensure the privacy of pregnancy termination or loss information; Family and medical leave, including paid leave; H.R.9261, the Comprehensive Paid Leave for Federal Employees Act; Gender equity and sex discrimination; H.Res.1385 and S.Res.785, resolutions celebrating the accomplishments of Title IX of the Education Amendments of 1972, and recognizing the need to continue pursuing the goal of educational opportunities for all women and girls; Issues related to workplace fairness and gender discrimination; LGBTQI+ rights and discrimination against LGBTQI+ people; Bans and restrictions on gender affirming care, including FY27 federal spending bills.

Client expense: $30,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE